Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In vitro assessment of mesoangioblast quality in patients with skeletal muscle atrophy
NL-OMON56403Terminated
- Sponsor
- Maastricht University Medical Center+
- Start
- Dec 2023
- Countries
- 1
01
Overview
Open-label trial in muscle atrophy, cachexia and Sarcopenia (3 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Immunophenotype characterization of mesoangioblasts, In vitro proliferation rate of mesoangioblasts and 1 more. Started Dec 2023; status: terminated.
02
Conditions
muscle atrophycachexiaSarcopenia
Beyond the preview
Go deeper on NL-OMON56403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56403.